BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 37860014)

  • 1. Mechanism of regulating macrophages/osteoclasts in attenuating wear particle-induced aseptic osteolysis.
    Yin Z; Gong G; Liu X; Yin J
    Front Immunol; 2023; 14():1274679. PubMed ID: 37860014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scutellarin inhibits RANKL-mediated osteoclastogenesis and titanium particle-induced osteolysis via suppression of NF-κB and MAPK signaling pathway.
    Zhao S; Sun Y; Li X; Wang J; Yan L; Zhang Z; Wang D; Dai J; He J; Wang S
    Int Immunopharmacol; 2016 Nov; 40():458-465. PubMed ID: 27728897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal implant debris-induced osteolysis.
    Hallab NJ; Cunningham BW; Jacobs JJ
    Spine (Phila Pa 1976); 2003 Oct; 28(20):S125-38. PubMed ID: 14560184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of XCL1/Lymphotactin Ameliorates Severity of Periprosthetic Osteolysis Triggered by Polyethylene-Particles.
    Tian Y; Terkawi MA; Onodera T; Alhasan H; Matsumae G; Takahashi D; Hamasaki M; Ebata T; Aly MK; Kida H; Shimizu T; Uetsuki K; Kadoya K; Iwasaki N
    Front Immunol; 2020; 11():1720. PubMed ID: 32849609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geraniin suppresses RANKL-induced osteoclastogenesis in vitro and ameliorates wear particle-induced osteolysis in mouse model.
    Xiao F; Zhai Z; Jiang C; Liu X; Li H; Qu X; Ouyang Z; Fan Q; Tang T; Qin A; Gu D
    Exp Cell Res; 2015 Jan; 330(1):91-101. PubMed ID: 25016282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semaphorin-3a, neuropilin-1 and plexin-A1 in prosthetic-particle induced bone loss.
    Saad S; Dharmapatni AASSK; Crotti TN; Cantley MD; Algate K; Findlay DM; Atkins GJ; Haynes DR
    Acta Biomater; 2016 Jan; 30():311-318. PubMed ID: 26602825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LY450139 Inhibited Ti-Particle-Induced Bone Dissolution via Suppressing Notch and NF-κB Signaling Pathways.
    Gao J; Wu P; Chi Y; Xu H; Zhao Y; Song N; Mao Y
    Calcif Tissue Int; 2022 Aug; 111(2):211-223. PubMed ID: 35588014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piperlongumine Inhibits Titanium Particles-Induced Osteolysis, Osteoclast Formation, and RANKL-Induced Signaling Pathways.
    Liu X; Diao L; Zhang Y; Yang X; Zhou J; Mao Y; Shi X; Zhao F; Liu M
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35270008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of melatonin on titanium particle-induced inflammatory bone resorption and osteoclastogenesis via suppression of NF-κB signaling.
    Ping Z; Wang Z; Shi J; Wang L; Guo X; Zhou W; Hu X; Wu X; Liu Y; Zhang W; Yang H; Xu Y; Gu Y; Geng D
    Acta Biomater; 2017 Oct; 62():362-371. PubMed ID: 28867647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of inflammatory cell infiltrate in periprosthetic osteolysis.
    Panez-Toro I; Heymann D; Gouin F; Amiaud J; Heymann MF; Córdova LA
    Front Immunol; 2023; 14():1310262. PubMed ID: 38106424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of wear particle-induced osteolysis by a novel V-ATPase inhibitor saliphenylhalamide through inhibition of osteoclast bone resorption.
    Qin A; Cheng TS; Lin Z; Cao L; Chim SM; Pavlos NJ; Xu J; Zheng MH; Dai KR
    PLoS One; 2012; 7(4):e34132. PubMed ID: 22509274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schisantherin A suppresses osteoclast formation and wear particle-induced osteolysis via modulating RANKL signaling pathways.
    He Y; Zhang Q; Shen Y; Chen X; Zhou F; Peng D
    Biochem Biophys Res Commun; 2014 Jul; 449(3):344-50. PubMed ID: 24845381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of NF-κB/NLRP3 axis in the progression of aseptic loosening of total joint arthroplasties: a review of molecular mechanisms.
    Qoreishi M; Panahi M; Dorodi O; Ghanbari N; Jousheghan SS
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Jul; 395(7):757-767. PubMed ID: 35377011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypericin suppresses osteoclast formation and wear particle-induced osteolysis via modulating ERK signalling pathway.
    Ouyang Z; Zhai Z; Li H; Liu X; Qu X; Li X; Fan Q; Tang T; Qin A; Dai K
    Biochem Pharmacol; 2014 Aug; 90(3):276-87. PubMed ID: 24950468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theaflavin-3,3'-digallate represses osteoclastogenesis and prevents wear debris-induced osteolysis via suppression of ERK pathway.
    Hu X; Ping Z; Gan M; Tao Y; Wang L; Shi J; Wu X; Zhang W; Yang H; Xu Y; Wang Z; Geng D
    Acta Biomater; 2017 Jan; 48():479-488. PubMed ID: 27838465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-106b inhibition suppresses inflammatory bone destruction of wear debris-induced periprosthetic osteolysis in rats.
    Yu B; Bai J; Shi J; Shen J; Guo X; Liu Y; Ge G; Lin J; Tao Y; Yang H; Xu Y; Qu Q; Geng D
    J Cell Mol Med; 2020 Jul; 24(13):7490-7503. PubMed ID: 32485091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-377 inhibits wear particle-induced osteolysis via targeting RANKL.
    Li W; Wang X; Chang L; Wang F
    Cell Biol Int; 2019 Jun; 43(6):658-668. PubMed ID: 30958621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of metallic magnesium degradation products on osteoclast-induced osteolysis and attenuation of NF-κB and NFATc1 signaling.
    Zhai Z; Qu X; Li H; Yang K; Wan P; Tan L; Ouyang Z; Liu X; Tian B; Xiao F; Wang W; Jiang C; Tang T; Fan Q; Qin A; Dai K
    Biomaterials; 2014 Aug; 35(24):6299-310. PubMed ID: 24816285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOST gene suppression stimulates osteocyte Wnt/β-catenin signaling to prevent bone resorption and attenuates particle-induced osteolysis.
    Jiao Z; Chai H; Wang S; Sun C; Huang Q; Xu W
    J Mol Med (Berl); 2023 May; 101(5):607-620. PubMed ID: 37121919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Icariin Alleviates Wear Particle-Induced Periprosthetic Osteolysis
    Guangtao F; Zhenkang W; Zhantao D; Mengyuan L; Qingtian L; Yuanchen M; Yuanfeng C; Qiujian Z
    Front Pharmacol; 2021; 12():746391. PubMed ID: 34803690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.